Decreased Wnt5a Expression is a Poor Prognostic Factor in Triple-Negative Breast Cancer.
about
WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transitionPretreatment TG/HDL-C Ratio Is Superior to Triacylglycerol Level as an Independent Prognostic Factor for the Survival of Triple Negative Breast Cancer Patients.Multiple Roles of WNT5A in Breast Cancer.Efficacy and Safety of Vinorelbine Plus Cisplatin vs. Gemcitabine Plus Cisplatin for Treatment of Metastatic Triple-Negative Breast Cancer After Failure with Anthracyclines and Taxanes.The crossroads of breast cancer progression: insights into the modulation of major signaling pathways.TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells
P2860
Decreased Wnt5a Expression is a Poor Prognostic Factor in Triple-Negative Breast Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Decreased Wnt5a Expression is a Poor Prognostic Factor in Triple-Negative Breast Cancer.
@ast
Decreased Wnt5a Expression is a Poor Prognostic Factor in Triple-Negative Breast Cancer.
@en
type
label
Decreased Wnt5a Expression is a Poor Prognostic Factor in Triple-Negative Breast Cancer.
@ast
Decreased Wnt5a Expression is a Poor Prognostic Factor in Triple-Negative Breast Cancer.
@en
prefLabel
Decreased Wnt5a Expression is a Poor Prognostic Factor in Triple-Negative Breast Cancer.
@ast
Decreased Wnt5a Expression is a Poor Prognostic Factor in Triple-Negative Breast Cancer.
@en
P2093
P2860
P356
P1476
Decreased Wnt5a Expression is a Poor Prognostic Factor in Triple-Negative Breast Cancer
@en
P2093
P2860
P356
10.12659/MSM.894821
P577
2016-01-01T00:00:00Z